GOT2 and neoplasm: In the cancer context, this pathway is frequently upregulated; GOT2 and Aspartate–Glutamate Carriers (AGC1/AGC2) may enhance aspartate supply to support growth, whereas inhibition of GOT2 or blockade of aspartate transport can limit cell proliferation and tumor growth (depending on model and context) (40, 42).